These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 35452635)
41. Mechanistic links between oxidative/nitrosative stress and tumor necrosis factor alpha in letrozole-induced murine polycystic ovary: biochemical and pathological evidences for beneficial effect of pioglitazone. Rezvanfar MA; Rezvanfar MA; Ahmadi A; Saadi HA; Baeeri M; Abdollahi M Hum Exp Toxicol; 2012 Sep; 31(9):887-97. PubMed ID: 22076494 [TBL] [Abstract][Full Text] [Related]
42. The promising effect of linagliptin and/or indole-3-carbinol on experimentally-induced polycystic ovarian syndrome. Kabel AM; Al-Shehri AH; Al-Talhi RA; Abd Elmaaboud MA Chem Biol Interact; 2017 Aug; 273():190-199. PubMed ID: 28619389 [TBL] [Abstract][Full Text] [Related]
43. Diacerein mitigates endocrine and cardio-metabolic disruptions in experimental PCOS mice model by modulating AdipoR1/ PON 1. Shah MZUH; Shrivastava VK; Muzamil S; Olaniyi KS BMC Endocr Disord; 2024 Jul; 24(1):109. PubMed ID: 38982395 [TBL] [Abstract][Full Text] [Related]
44. Therapeutic Efficacy of Melatonin Against Polycystic Ovary Syndrome (PCOS) Induced by Letrozole in Wistar Rat. Basheer M; Rai S; Ghosh H; Ahmad Hajam Y Pak J Biol Sci; 2018 Jan; 21(7):340-347. PubMed ID: 30417994 [TBL] [Abstract][Full Text] [Related]
45. Diacerein ameliorates induced polycystic ovary in female rats via modulation of inflammasome/caspase1/IL1β and Bax/Bcl2 pathways. Refaie MMM; El-Hussieny M; Abdelraheem WM Naunyn Schmiedebergs Arch Pharmacol; 2022 Mar; 395(3):295-304. PubMed ID: 34994825 [TBL] [Abstract][Full Text] [Related]
46. Hyperhomocysteinemia and hyperandrogenemia share PCSK9-LDLR pathway to disrupt lipid homeostasis in PCOS. Mondal K; Chakraborty P; Kabir SN Biochem Biophys Res Commun; 2018 Sep; 503(1):8-13. PubMed ID: 29660344 [TBL] [Abstract][Full Text] [Related]
47. Novel promising reproductive and metabolic effects of Cicer arietinum L. extract on letrozole induced polycystic ovary syndrome in rat model. Ali SE; El Badawy SA; Elmosalamy SH; Emam SR; Azouz AA; Galal MK; Abd-Elsalam RM; Issa MY; Hassan BB J Ethnopharmacol; 2021 Oct; 278():114318. PubMed ID: 34111539 [TBL] [Abstract][Full Text] [Related]
48. Letrozole Rat Model Mimics Human Polycystic Ovarian Syndrome and Changes in Insulin Signal Pathways. Xu J; Dun J; Yang J; Zhang J; Lin Q; Huang M; Ji F; Huang L; You X; Lin Y Med Sci Monit; 2020 Jul; 26():e923073. PubMed ID: 32638705 [TBL] [Abstract][Full Text] [Related]
49. Cellular and molecular mechanisms of pentoxifylline's beneficial effects in experimental polycystic ovary. Rezvanfar MA; Saadat S; Shojaei Saadi HA; Mansoori P; Saeedi S; Gooshe M; Baeeri M; Abdollahi M Theriogenology; 2015 Apr; 83(6):968-77. PubMed ID: 25557188 [TBL] [Abstract][Full Text] [Related]
51. Role of high-fat diet on letrozole-induced polycystic ovarian syndrome in rats. Begum N; Manipriya K; Veeresh B Eur J Pharmacol; 2022 Feb; 917():174746. PubMed ID: 34998791 [TBL] [Abstract][Full Text] [Related]
52. Promising drug candidates for the treatment of polycystic ovary syndrome (PCOS) as alternatives to the classical medication metformin. Anbar HS; Vahora NY; Shah HL; Azam MM; Islam T; Hersi F; Omar HA; Dohle W; Potter BVL; El-Gamal MI Eur J Pharmacol; 2023 Dec; 960():176119. PubMed ID: 37852569 [TBL] [Abstract][Full Text] [Related]
53. The effect of Nateglinide and Octreotide on follicular morphology and free radical scavenging system in letrazole-induced rat model of PCOS. Kirici P; Kaplan S; Annac E; Tanriverdi ES; Cagiran FT; Kali Z; Mavral N; Taskapan MC Eur Rev Med Pharmacol Sci; 2022 Dec; 26(23):8893-8902. PubMed ID: 36524509 [TBL] [Abstract][Full Text] [Related]
54. Therapeutic potential of quercetin in an animal model of PCOS: Possible involvement of AMPK/SIRT-1 axis. Mihanfar A; Nouri M; Roshangar L; Khadem-Ansari MH Eur J Pharmacol; 2021 Jun; 900():174062. PubMed ID: 33798596 [TBL] [Abstract][Full Text] [Related]
55. Alleviative Effects of Adipose Tissue-derived Stem Cells and α-NETA on Metabolic, Biochemical, and Endocrine Parameters in a Letrozole-induced Rat Model of PCOS. Nejabati HR; Nikzad S; Roshangar L Curr Pharm Des; 2023; 29(24):1929-1938. PubMed ID: 37584355 [TBL] [Abstract][Full Text] [Related]
56. A Rat Model of Polycystic Ovary Syndrome with Insulin Resistance Induced by Letrozole Combined with High Fat Diet. Wang MX; Yin Q; Xu X Med Sci Monit; 2020 May; 26():e922136. PubMed ID: 32448863 [TBL] [Abstract][Full Text] [Related]
57. Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome. Du DF; Li XL; Fang F; Du MR Gynecol Endocrinol; 2014; 30(12):885-9. PubMed ID: 25170777 [TBL] [Abstract][Full Text] [Related]
58. Quercetin Decreases Insulin Resistance in a Polycystic Ovary Syndrome Rat Model by Improving Inflammatory Microenvironment. Wang Z; Zhai D; Zhang D; Bai L; Yao R; Yu J; Cheng W; Yu C Reprod Sci; 2017 May; 24(5):682-690. PubMed ID: 27634381 [TBL] [Abstract][Full Text] [Related]
59. Uterine anomalies in cell proliferation, energy homeostasis and oxidative stress in PCOS hamsters, M. auratus: Therapeutic potentials of melatonin. Hansda SR; Haldar C Life Sci; 2021 Sep; 281():119755. PubMed ID: 34175318 [TBL] [Abstract][Full Text] [Related]
60. Fenofibrate ameliorates letrozole-induced polycystic ovary in rats via modulation of PPARα and TNFα/CD95 pathway. Morsy MA; El-Hussieny M; Zenhom NM; Nair AB; Venugopala KN; Refaie MMM Eur Rev Med Pharmacol Sci; 2022 Oct; 26(20):7359-7370. PubMed ID: 36314306 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]